2. Academic Validation
  3. Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in Mycobacterium tuberculosis

Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in Mycobacterium tuberculosis

  • ACS Infect Dis. 2021 Jan 8;7(1):141-152. doi: 10.1021/acsinfecdis.0c00675.
Shipra Grover 1,  Curtis A Engelhart 1,  Esther Pérez-Herrán 2,  Wei Li 3,  Katherine A Abrahams 4,  Kadamba Papavinasasundaram 5,  James M Bean 6,  Christopher M Sassetti 5,  Alfonso Mendoza-Losana 2,  Gurdyal S Besra 4,  Mary Jackson 3,  Dirk Schnappinger 1
Affiliations

Affiliations

  • 1 Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York 10065, United States.
  • 2 TB Research Unit, Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.
  • 3 Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523, United States.
  • 4 Institute of Microbiology and Infection, School of Biological Sciences, University of Birmingham, Birmingham B15 2TT, U.K.
  • 5 Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts 01655, United States.
  • 6 Sloan Kettering Institute, New York, New York 10065, United States.
PMID: 33319550 DOI: 10.1021/acsinfecdis.0c00675
Abstract

MmpL3, an essential mycolate transporter in the inner membrane of Mycobacterium tuberculosis (Mtb), has been identified as a target of multiple, chemically diverse antitubercular drugs. However, several of these molecules seem to have secondary targets and inhibit Bacterial growth by more than one mechanism. Here, we describe a cell-based assay that utilizes two-way regulation of MmpL3 expression to readily identify MmpL3-specific inhibitors. We successfully used this assay to identify a novel guanidine-based MmpL3 inhibitor from a library of 220 compounds that inhibit growth of Mtb by largely unknown mechanisms. We furthermore identified inhibitors of cytochrome bc1-aa3 oxidase as one class of off-target hits in whole-cell screens for MmpL3 inhibitors and report a novel sulfanylacetamide as a potential QcrB inhibitor.

Keywords

antibiotics; drug discovery; molecular genetics; mycolic acids; respiration; targeted whole-cell screen.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z